Search results
Results from the WOW.Com Content Network
Competition in cancer treatment continues to intensify, potentially challenging Merck's market leadership. At 10.2 times forward earnings, Merck stock trades at a valuation that reflects both its ...
Main Menu. News. News
No matter how well the stock market is performing, investors can always find some companies that aren't keeping pace with broader equities. This year, pharmaceutical giant Merck (NYSE: MRK) is it ...
In terms of valuation, Merck stock is trading at a forward price-to-earnings (P/E) ratio of 14, which is near a peer-group average of 15 among pharmaceutical leaders like Johnson & Johnson, Pfizer ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Merck wasn’t one of them. The 10 stocks that made the cut ...
Merck Research Laboratories in South San Francisco, California. In May 2002, The Bill & Melinda Gates Foundation purchased stock in Merck. [76] From 2002 through 2005, the Australian affiliate of Merck paid publishing house Elsevier an undisclosed amount to produce eight issues of a medical journal, the Australasian Journal of Bone and Joint ...
Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs market. Merck on Dec. 16 said it had just inked a license agreement with a Chinese biopharma company called Hansoh ...
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare ...